Skip to content

Comparison of the effects of real-life cue exposure (CE) to a standardized virtual reality (VR) cue exposure and to a VR-CE individualized using artificial intelligence on cue-induced alcohol craving

Comparison of the effects of real-life cue exposure (CE) to a standardized virtual reality (VR) cue exposure and to a VR-CE individualized using artificial intelligence on cue-induced alcohol craving - VREx-AI

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00037241
Enrollment
48
Registered
2025-06-23
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Use Disorder (DSM-5)

Interventions

Group 1: Six-armed randomized controlled cross-over study comparing the effects of three different cue-exposure conditions at different time points: A – alcohol cue exposure in a BarLab setting
B – alcohol cue exposure in a standardized virtual reality setting
C – alcohol cue exposure in an AI-personalized virtual reality setting Group 1: ABC Group 2: Group 2: ACB Group 3: Group 3: BCA Group 4: Group 4: BAC Group 5: Group 5: CBA Group 6: Group 6: CAB

Sponsors

Zentralinstitut für Seelische Gesundheit Klinik für Abhängiges Verhalten und Suchtmedizin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: • Diagnosis of an alcohol use disorder (AUD) according to the DSM-5 (i.e. meeting >= 2 criteria) • Ability of the individual to understand the character and the individual consequences of the study • Capacity to provide written informed consent

Exclusion criteria

Exclusion criteria: • Current psychotic or bipolar disorder or current severe depressive episode with suicidal ideations • Any withdrawal symptoms at the time of the study visit (CIWA score >3) • Breath alcohol concentration > 0.0 at the time of the study visit • Positive drug screening (amphetamines/ecstasy, opiates, cocaine, barbiturates, cannabis, psychotropic drugs) • Severe comorbidities and/or complications that demand invasive surgery and/or intensive care • Acute suicidal tendency or acute endangerment of self and others

Design outcomes

Primary

MeasureTime frame
The difference of alcohol craving intensity from baseline (of each session) to three minutes into cue exposure, measured using a Visual Analogue Scale (VAS) ranging from 0 ("no craving") to 100 ("most intense craving")

Secondary

MeasureTime frame
Differences from before the exposure to three minutes after the start of the cue exposure in: 1. Alcohol Urge Questionnaire score 2. Subjective arousal 3. Subjective valence 4. Heart rate variability 5. Eye-Tracking parameters (Dwell Time, First Fixation Duration of the alcohol stimulus)

Countries

Germany

Contacts

Public ContactPatrick Bach

Zentralinstitut für Seelische Gesundheit Klinik für Abhängiges Verhalten und Suchtmedizin

patrick.bach@zi-mannheim.de+49 621/ 1703-3888

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026